{
  "url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2024/article-2",
  "json_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2024/article-2.json",
  "legislation": "ukdsi/2024/9780348254105",
  "legislation_title": "The Misuse of Drugs Act 1971 (Amendment) Order 2024",
  "legislation_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2024",
  "path": "article/2",
  "kind": "article",
  "number": "2",
  "heading": "Amendments to the Misuse of Drugs Act 1971",
  "text": "(1) The following amendments are made to Schedule 2 to the Misuse of Drugs Act 1971.\n(2) In Part 1 (which specifies the drugs which are subject to control as Class A drugs) in paragraph 1(a)—\n(a) after “Bezitramide.” insert “Brorphine.”;\n(b) after “Bufotenine.” insert “Butonitazene.”;\n(c) after “Ecgonine, and any derivate of ecgonine which is convertible to ecgonine or to cocaine.” insert “Ethyleneoxynitazene.”;\n(d) after “Eticyclidine.” insert “Etodesnitazene (etazene).”;\n(e) after “Fentanyl.” insert “Flunitazene.”;\n(f) after “Isomethadone.” insert “Isotonitazene.”;\n(g) after “Methyldihydromorphine (6-methyldihydromorphine).” insert—\n“Metodesnitazene (metazene).\nMetonitazene.”;\n(h) after “Properidine (1-methyl-4-phenyl-piperdine-4-carboxylic acid isopropyl ester).” insert “Protonitazene.”;\n(i) after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45).” insert—\n“N-Desethyl etonitazene.\nN-Desethylisotonitazene.\nN-Desethyl protonitazene.”;\n(j) after “4-Phenylpiperidine-4-carboxylic acid ethyl ester.” insert—\n“N-Piperidinyl-etonitazene (etonitazepipne).\nN-Pyrrolidino-etonitazene (etonitazepyne).\nN-Pyrrolidino protonitazene.”.\n(3) In Part 2 (which specifies the drugs which are subject to control as Class B drugs) in paragraph 1(a)—\n(a) after “Codeine.” insert “Cumyl-PeGaClone.”;\n(b) after “Dihydrocodeine.” insert—\n“Diphenidine.\nEphenidine.”;\n(c) after “Methcathinone” insert “Methoxyphenidine.”.\n(4) In Part 3 (which specifies the drugs which are subject to control as Class C drugs) in paragraph 1(a) after “Pyrovalerone.” insert “Remimazolam.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Subparagraph (a) was designated as such by S.I. 1977/1243. Relevant amending instruments are S.I. 1984/859 and S.I. 2015/215. There are other amendments to Part 1 of Schedule 2 which are not relevant to this Order."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "Subparagraph (a) of paragraph 1 was designated as such by S.I. 1984/859. A relevant amending instrument is S.I. 1998/750. There are other amendments to Part 2 of Schedule 2 which are not relevant to this Order."
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "Subparagraph (a) of paragraph 1 was designated as such by S.I. 1996/1300. A relevant amending instrument is S.I. 1986/2230. There are other amendments to Part 3 of Schedule 2 which are not relevant to this Order."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2024/9780348254105/article/2",
    "retrieved_at": "2026-10-30T14:42:15.251053+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}